We provide EQA schemes for 3 core areas of laboratory medicine; Inherited genetic disorders (Germline mutation testing), Cancer (Somatic mutation testing), and Technological approaches used in testing.
Most of our schemes are covered under our UKAS accreditation. Where possible we offer multi-language support to allows laboratories to submit their reports in their native language. Each scheme has a set of core requirements which are defined in the scheme catalogue. Any differences or exceptions are clearly shown.
If you are a lab that is not providing a full clinical interpretation of a test result (e.g., kit manufactures, commercial sequencing hubs etc), then please contact the EMQN office for advice on the ways you can participate.
See our scheme catalogue for more details.